Previous Close | 21.02 |
1-Year Change | 75.75% |
6-Months Change | -4.28% |
3-Months Change | -20.44% |
Moving Avg (50d) | 23.997 |
Moving Avg (200d) | 21.18 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 0.969B |
Beta (3-Years) | 2.09 |
Revenue Growth (ttm) | -17% |
Net Profit Margin (ttm) | -58.24% |
Return On Assets (ttm) | -19.59% |
EPS (ttm) | -1.64 |
PE Ratio (ttm) | -12.82 |
Dividend Yield | % |
Asset Description: | BioLife Solutions, Inc. |
Predicted Direction: | Buy |
Signal Strength: | Neutral |
Forecast Date: | 2024-11-19 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
24.51 | 23.76 | 23.259 | 22.509 | 21.259 | 20.008 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Health Care Supplies |
Country: | United States |